3rd Annual Risk Management and Pharmacovigilance America Summit 2018

23 - 25 Oct 2018, Boston

The 3rd Annual Risk Management and Pharmacovigilance America Summit will be held in Boston this coming October and as every year, it will create great atmosphere for PV professionals to network and discuss current issues in the drug safety world. You will hear about all the necessary topics related to the new updates in regulatory, new techniques in digital pharmacovigilance, real examples of automation in PV, how to build a new PV department, Reference Safety Information (RSI) requirements, challenges in adverse events reporting, developing a PV audit strategy, and many more. Do not forget to highlight the dates 23 - 25 October in your calendar and prepare yourself for 3 days full of great presentations, discussions and networking. We are looking forward to meeting you in the best Pharmacovigilance and Risk Management Summit soon!


Key Speakers

Andrea Best

Executive Medical Director, Pharmacovigilance and Patient Safety


Anand Ananthakrishnan

Director, PV Safety System and Operations

Fresenius Medical Care 

David Chonzi
Vice President- Head of Patient Safety and Pharmacovigilance

Kite Pharma


Kevin Leary

Director, Clinical Safety and Risk Management

Merck Research Labs

Bruno Mendez



Sandra Raff

Senior Director, Global Drug Safety


Key topics

  • The interface of digital medicine and drug safety 
  • Navigating the complexities of Reference Safety Information (RSI) in the clinical trial setting 
  • Immune-Related Adverse Events in oncology
  • Artificial Intelligence and Machine Learning in drug safety
  • How to develop an overall business partner PV audit strategy?
  • New challenges in global safety governance
  • Building a drug safety department
  • Benefit-risk assessment and patient centricity in drug safety 
  • Emerging new technologies in PV


Who Should attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical industry involved in:

  • Drug Safety
  • Pharmacovigilance
  • Risk Management
  • Clinical Safety
  • Data management and data mining
  • Safety & Risk Management
  • Signal Detection
  • Benefit-Risk Assessment
  • Safety Evaluation
  • Regulatory Affairs, Pharmacovigilance
  • Safety System


  • PV Governance
  • Safety Surveillance
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Market Research Programs
  • Medical Safety
  • Medical Information 
  • Pharmacoepidemiology
  • Quality Pharmacovigilance 


A.      The Risk Management and Pharmacovigilance America Summit will be a great opportunity to meet     the worldwide experts in the drug safety field. After our successful PV and RM meetings in Europe, we are moving to another continent and you have the chance to be part of it. In October, Boston will be the place, where the top experts from companies such as Merck, Pfizer, Amgen, Novartis, Genentech, Gilead Sciences, Takeda and others, will speak about interesting case studies from different areas within the drug safety. You will get the best advices on how to implement new legislation into the real world settings, how to deal with increasing volumes of ICSRs, how to improve the pharmacovigilance and risk management procedures in your company, Benefit-Risk Evaluations and frameworks, signal detection, the future of pharmacovigilance, comparison of the US, EU and Latin America pharmacovigilance processes, etc. You will also find many networking and discussing opportunities there, where you will be able to exchange practical insights with other participants and pharmacovigilance/risk management experts. Save the date from 18th to 20th October and do not miss any news from the pharmacovigilance world in 2016. 



Allan Lloyds Group
Trnavska cesta 82, 821 02 Bratislava, Slovakia

+421 221 025 322


Follow us